Aldeyra Therapeutics, Inc. (ALDX) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -5.11M | -5.3M | -7.02M | -8.56M | -12.47M | -12.04M | -7.97M | -13.22M | -9.97M | 500.44K | -8.02M | -13.36M | -9.44M | -11.23M | -12.57M | -19.96M | -12.87M | -11.58M | -8.43M | -9.07M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 59.02% | 55.97% | 11.96% | 35.31% | -25.04% | -2505.25% | 0.62% | 1% | -5.6% | 104.46% | 36.18% | 33.07% | 26.64% | 2.99% | -49.09% | -119.99% | 4.44% | -39.2% | -35.22% | -19.7% |
| Net Income | -3.45M | -6.46M | -7.69M | -9.77M | -9.93M | -15.81M | -15.11M | -16.85M | -8.08M | -4.75M | -8.19M | -8.99M | -15.62M | -12.9M | -14.55M | -17.78M | -16.79M | -15.75M | -15.79M | -14.94M |
| Depreciation & Amortization | 66.6K | 65.12K | 63.68K | 62.28K | 60.91K | 64.37K | 62.99K | 61.63K | 60.63K | 66.47K | 65K | 64.34K | 66.97K | 66.64K | 65.31K | 64.01K | 62.74K | 61.27K | 68.35K | 66.69K |
| Stock-Based Compensation | 0 | 1.09M | 2.58M | 196.56K | 2.22M | 1.26M | 3.23M | 1.94M | 1.55M | -800.34K | 789.22K | 1.57M | 4.19M | 2.82M | 2.24M | 1.29M | 1.94M | 984.47K | 1.42M | 2.32M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.76M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -937.19K | 6.29K | -216.19K | -379.01K | -75.12K | -421.32K | -471K | -487.63K | -113.71K | -1.69M | 95.94K | 100.34K | 72.62K | 61.89K | 65.03K | 77.41K | 79.57K | 82.8K | 82.8K | 102.37K |
| Working Capital Changes | -786.88K | 673 | -1.76M | 1.33M | -4.75M | 2.87M | 4.32M | 2.11M | -3.39M | 5.92M | -788.2K | -6.11M | 1.84M | -1.28M | -388.1K | -3.61M | 1.84M | 3.05M | 5.79M | 3.37M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -17.11K | 145.04K | -1.02M | 683.38K | 165.69K | -6.47K | -67.52K | -25.86K | -1.06M | 1.09M | -23.62K | -158.87K | 296.06K | -1.17M | 1.04M | -2.18M | 1.42M | 551.77K | -626.53K | 645.87K |
| Cash from Investing | 0 | 16M | 25M | -554.13K | 7.29M | -1.56M | 5.26M | -18.24M | -30.38M | 0 | 0 | 0 | 30M | 27M | 19.02M | -17.94M | -58.03M | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -16.32K | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -17.94K | 0 | 0 | 0 | 0 |
| Cash from Financing | 71.14K | 0 | 120.75K | 0 | 1M | 7.78K | -197.39K | 0 | 18.19K | -1.01M | -315.76K | 5.29K | 52.56K | 0 | 1.2M | 0 | 23.32K | 0 | 63.78K | 120.37M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | -292.5K | 0 | 0 | 0 | -1.04M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 71.14K | 0 | 120.75K | 0 | 1M | 300.28K | -197.39K | 0 | 18.19K | 30.19K | 217.19K | 5.29K | 52.56K | 0 | 1.2M | 0 | 23.32K | 0 | 0 | 119.76M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -532.95K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 63.78K | 606.84K |
| Net Change in Cash | -5.04M | 10.7M | 18.1M | -9.11M | -4.18M | -13.59M | -2.91M | -21.46M | -90.33M | -511.87K | -8.34M | -13.35M | 20.61M | 15.77M | 65.14M | -37.9M | -10.88M | -11.58M | -8.37M | 111.3M |
| Free Cash Flow | -5.11M | -5.3M | -7.02M | -8.56M | -12.47M | -12.04M | -7.97M | -13.22M | -9.97M | 500.44K | -8.02M | -13.36M | -9.44M | -11.23M | -12.57M | -19.96M | -12.89M | -11.58M | -8.43M | -9.07M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 59.02% | 55.97% | 11.96% | 35.31% | -25.04% | -2505.25% | 0.62% | 1% | -5.6% | 104.46% | 36.18% | 33.07% | 26.73% | 2.99% | -49.09% | -119.99% | 4.38% | -39.2% | -35.22% | -19.7% |
| FCF per Share | -0.08 | -0.09 | -0.12 | -0.14 | -0.21 | -0.20 | -0.13 | -0.22 | -0.17 | 0.01 | -0.14 | -0.23 | -0.16 | -0.19 | -0.22 | -0.34 | -0.22 | -0.20 | -0.15 | -0.17 |
| FCF Conversion (FCF/Net Income) | 1.48x | 0.82x | 0.91x | 0.88x | 1.26x | 0.76x | 0.53x | 0.78x | 1.23x | -0.11x | 0.98x | 1.49x | 0.60x | 0.87x | 0.86x | 1.12x | 0.77x | 0.73x | 0.53x | 0.61x |
| Interest Paid | 0 | 0 | 0 | 425.5K | 0 | 424.63K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 356.71K | 0 | 0 | 0 | 326.08K | 329.67K | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |